CN1261109C - 调节、治疗或改善血液功能的复方制剂 - Google Patents
调节、治疗或改善血液功能的复方制剂 Download PDFInfo
- Publication number
- CN1261109C CN1261109C CN 02134075 CN02134075A CN1261109C CN 1261109 C CN1261109 C CN 1261109C CN 02134075 CN02134075 CN 02134075 CN 02134075 A CN02134075 A CN 02134075A CN 1261109 C CN1261109 C CN 1261109C
- Authority
- CN
- China
- Prior art keywords
- grams
- present
- radix notoginseng
- blood
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 13
- 230000000157 blood function Effects 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 title claims description 6
- 238000009472 formulation Methods 0.000 title 1
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 26
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 26
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- 239000000284 extract Substances 0.000 claims abstract description 11
- 230000000975 bioactive effect Effects 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 claims description 15
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 claims description 14
- 239000004615 ingredient Substances 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- 239000000469 ethanolic extract Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 235000002917 Fraxinus ornus Nutrition 0.000 claims description 3
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 2
- 241001289435 Astragalus brachycalyx Species 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 230000000004 hemodynamic effect Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 abstract description 2
- 108010003541 Platelet Activating Factor Proteins 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 230000006872 improvement Effects 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 abstract 2
- 208000035240 Disease Resistance Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 210000005096 hematological system Anatomy 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 229940119485 safflower extract Drugs 0.000 abstract 1
- 241000628997 Flos Species 0.000 description 8
- 241000700159 Rattus Species 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 241001597008 Nomeidae Species 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 101710095342 Apolipoprotein B Proteins 0.000 description 2
- 102100040202 Apolipoprotein B-100 Human genes 0.000 description 2
- 102000018619 Apolipoproteins A Human genes 0.000 description 2
- 108010027004 Apolipoproteins A Proteins 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 244000182067 Fraxinus ornus Species 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229960002662 propylthiouracil Drugs 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02134075 CN1261109C (zh) | 2002-11-12 | 2002-11-12 | 调节、治疗或改善血液功能的复方制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02134075 CN1261109C (zh) | 2002-11-12 | 2002-11-12 | 调节、治疗或改善血液功能的复方制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1500499A CN1500499A (zh) | 2004-06-02 |
CN1261109C true CN1261109C (zh) | 2006-06-28 |
Family
ID=34231370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02134075 Expired - Fee Related CN1261109C (zh) | 2002-11-12 | 2002-11-12 | 调节、治疗或改善血液功能的复方制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1261109C (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2622452C (en) | 2005-09-14 | 2010-11-16 | Ajinomoto Co., Inc. | Hemodynamics improving agent |
CN103816086B (zh) * | 2014-03-04 | 2015-12-30 | 天津嘉氏堂科技有限公司 | 一种中药美白组合物及制备方法及应用 |
CN105963369A (zh) * | 2016-04-30 | 2016-09-28 | 孟令刚 | 一种具有治疗心脑血管疾病、高血脂和高血糖功能的中药组合物 |
CN115336753A (zh) * | 2022-04-26 | 2022-11-15 | 广东长兴生物科技股份有限公司 | 一种美白红花干膏软胶囊及其制造工艺 |
-
2002
- 2002-11-12 CN CN 02134075 patent/CN1261109C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1500499A (zh) | 2004-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111686147A (zh) | 一种杜仲提取物及其在治疗骨质疏松中的应用 | |
CN101045106A (zh) | 一种治疗肺热咳嗽、高热的中药组合物 | |
CN1116894C (zh) | 治疗心血管病的药物 | |
CN101053621A (zh) | 一种治疗肥胖症的中药组合物及其制备方法 | |
CN1261109C (zh) | 调节、治疗或改善血液功能的复方制剂 | |
CN1270697C (zh) | 口服纳米营养乳剂的制备方法 | |
CN106728679B (zh) | 一种用于抗骨量丢失的分子中药缓释片及其制备方法 | |
CN1173707C (zh) | 一种含野黄芩甙和咖啡酰奎宁酸的药用组合物 | |
CN102068653A (zh) | 一种治疗肝病的藏药制剂的制备方法 | |
CN1709451A (zh) | 一种用于治疗肝胆疾病的的叶下珠制剂及其制备方法 | |
CN1182858C (zh) | 养心茶胶囊及其制备方法 | |
CN1919026A (zh) | 一种具有抗氧化作用的绞股蓝保健茶及其制备方法 | |
CN1081924C (zh) | 包括虫草和巴西榥榥木的药物组合物 | |
CN1236810C (zh) | 一种治疗胃炎的中药 | |
CN1261151C (zh) | 治疗急、慢性胆囊炎的药物及其制备方法 | |
CN1709319A (zh) | 熊胆开明片 | |
CN1589853A (zh) | 治疗粘膜性溃疡的复方制剂 | |
CN1559523A (zh) | 脑得生软胶囊及其制备方法 | |
CN1210039C (zh) | 用于防治心脑血管病和糖尿病并发症的三七总皂苷与阿魏酸组合物及其应用 | |
CN1088450A (zh) | 治疗高血脂的制剂优降脂 | |
CN110215474B (zh) | 一种活血化瘀中药组合物及其应用 | |
CN1051934C (zh) | 一种治疗癫痫病的中药及其制备方法 | |
CN1193787C (zh) | 北冬虫夏草的用途 | |
CN1274334C (zh) | 止泻药物组合物及其制造方法 | |
CN1113148A (zh) | 喉症散及制配方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: Haobang Pharmaceutical Co., Ltd., Yunnan Document name: Notification that Application Deemed not to be Proposed |
|
ASS | Succession or assignment of patent right |
Owner name: HAOBANG PHARMACEUTICAL CO., LTD., YUNNAN Free format text: FORMER OWNER: KUNMING SHANYU BIOENGINEERING LTD Effective date: 20130910 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 650051 KUNMING, YUNNAN PROVINCE TO: 650000 KUNMING, YUNNAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130910 Address after: 650000 Yunnan Province, Kunming city Wuhua District No. 604 Xuefu Dingli Industrial Park Patentee after: Haobang Pharmaceutical Co., Ltd., Yunnan Address before: 16, building 650051, Ruyi building, Renmin Middle Road, Kunming, Yunnan Patentee before: Kunming Shanyu bioengineering Ltd |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Liu Ruiming Document name: payment instructions |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Liu Ruiming Document name: Notice of termination of patent right |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060628 Termination date: 20201112 |
|
CF01 | Termination of patent right due to non-payment of annual fee |